Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants

By HospiMedica International staff writers
Posted on 07 Oct 2026

Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. More...

This combination can complicate decisions about when to consider deep brain stimulation. New findings now suggest that the timing of deep brain stimulation may influence memory and executive function outcomes in this genetically predisposed group.

The study was led by an international research team with involvement from Hackensack Meridian Neuroscience Institute (Hackensack, NJ, USA) at JFK University Medical Center and Hackensack Meridian School of Medicine. The work focused on deep brain stimulation, or DBS, a surgical therapy that functions like a pacemaker for the brain. DBS uses an implanted battery to deliver steady, mild electrical pulses to specific brain areas affected by Parkinson’s disease. These pulses help override abnormal brain signals that contribute to tremor, stiffness and involuntary movement.

Researchers analyzed data from 343 patients treated across 10 medical centers in the United States and Europe. They compared cognitive outcomes over time in patients with and without GBA1 mutations. The analysis also examined whether DBS was performed early or late in the course of Parkinson’s disease. The findings were published in Movement Disorders on October 1, 2026.

The results showed that cognitive risk in GBA1 mutation carriers was strongly linked to surgical timing. Patients with the mutation who received DBS later in their disease course had a significantly faster decline in cognitive abilities than those treated earlier. Among patients without the mutation, DBS timing did not affect cognitive outcomes. The data identified the first seven to eight years after Parkinson’s diagnosis as an important window for intervention.

The findings support earlier genetic testing as part of DBS evaluation in Parkinson’s disease. Identifying GBA1 status earlier could help patients and clinical teams weigh potential motor benefits against cognitive risks. The authors emphasized that a GBA1 variant should not automatically exclude patients from DBS. Instead, genetic information may help guide a more individualized treatment timeline.

“We may be approaching a turning point in how we use deep brain stimulation for Parkinson's disease. For decades, DBS decisions have largely been based on a patient's symptoms and clinical characteristics. Our research suggests that a patient's genetics—and importantly, the timing of surgery—may also matter. The future of DBS may not simply be deciding who should receive it, but identifying the right window to intervene for each individual patient. That moves us closer to truly personalized treatment for Parkinson's disease,” said Dr. Gian Pal, chief of neurology and director of the Movement Disorders Program at Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and associate professor of neurology at Hackensack Meridian School of Medicine.

Related Links
Hackensack Meridian Neuroscience Institute 


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Gas Analyzer
GE SAM
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.